Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dasatinib (sprycel) (3 trials)
Leukemia (Phase 2)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Trials (3 total)
Trial APIs (1 total)